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IranIntroduction: In many developing countries, like Iran, newborns receive the BCG vaccination
for prophylaxis against mycobacterial infections. Although in many children or infants BCG
infection after BCG vaccination is rare, children with primary immunodeficiency are at high
risk of developing BCG-osis. According to many studies, some cytokines such as IL-12 play a
major role in immunological responses in dealing with mycobacterial infections. There-
fore, this research studies the relationship between polymorphism of genes encoding this
cytokine and BCG-osis in Iranian children.
Method: Thirty-four children up to 7 years old with BCG-osis and 34 healthy children vacci-
nated with BCG during the first two days of life were chosen for this analysis. DNA samples
were extracted from both groups. Single nucleotide polymorphisms (SNPs) in IL-12 (at +705,
+1158, +1196 and +1637) genes were assessed using PCR-RFLP. Allele and genotype frequen-
cies in cases and controls were compared using the Pearson Chi-Square test.
Result: The prevalence of IL-12 705 AG (heterozygote mutant) genotype was 50% in patients,
but in the control group this rate was 38.2%. Likewise, AA (frequent hemozygote) genotypes
were 52.9% and 38.2% in patients and control groups, respectively (p-Value >0.05). It was
observed only homozygote alleles for 1158, 1196, 1637 and 1664 positions in both patients
and control groups. However, there was no significant association between case and con-
trol groups.
Conclusions: BCG vaccination in infants can cause protective immunity, and IL-12 plays an
important role in immune responses. However, this study did not show any significant
association between polymorphisms in IL-12 (at +705, +1158, +1196 and +1637) and risk
of developing BCG-osis.
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